The infiltration of CD8 positive lymphocytes was significantly associated with improved survival in osteosarcoma patients treated with zoledronic acid, suggesting a positive immunoregulatory role of CD8 positive lymphocytes in inhibiting osteosarcoma growth and metastasis (Gomez-Brouchet et al., 2017). Here, CD8A is linked to osteosarcoma.